Literature DB >> 16214215

Mannose-binding lectin gene polymorphism and its impact on human immunodeficiency virus 1 infection.

Antonio Carlos Rosário Vallinoto1, Marcos Rogério Menezes-Costa, Anna Elizabeth Martins Alves, Luiz Fernando Almeida Machado, Vânia Nakauth de Azevedo, Lia Lobato Batista Souza, Marluísa de Oliveira Guimarães Ishak, Ricardo Ishak.   

Abstract

Mannose-binding lectin (MBL) is a serum protein whose low concentration is associated with the occurrence of allele variants named MBL*B, MBL*C and MBL*D. The present study investigated the association between MBL gene polymorphism and the susceptibility to HIV-1 infection. The study of 145 HIV-1-infected subjects and 99 healthy controls showed the presence of alleles MBL*A, MBL*B and MBL*D, whose frequencies were 69%, 22% and 09% among patients and 71%, 13% and 16% among healthy controls, respectively. The presence of the variant MBL*B was associated with higher plasma viral load levels, suggesting the importance of the MBL gene polymorphism in the clinical evolution of HIV-1-infected patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16214215     DOI: 10.1016/j.molimm.2005.09.001

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  9 in total

1.  Recombinant form of human wild type mannan-binding lectin (MBL/A) but not its structural variant (MBL/C) promotes phagocytosis of zymosan by activating complement.

Authors:  Rema Rajagopalan; Takazvida Nyaundi; Veena P Salvi; Nenoo Rawal
Journal:  Mol Immunol       Date:  2010-06-25       Impact factor: 4.407

2.  Mannose-binding lectin in HIV infection.

Authors:  Sarah Eisen; Agnieszka Dzwonek; Nigel J Klein
Journal:  Future Virol       Date:  2008-05       Impact factor: 1.831

Review 3.  Infections of people with complement deficiencies and patients who have undergone splenectomy.

Authors:  Sanjay Ram; Lisa A Lewis; Peter A Rice
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 4.  Host genetics influences on HIV type-1 disease.

Authors:  Jacques Fellay
Journal:  Antivir Ther       Date:  2009

5.  Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure.

Authors:  Jairam R Lingappa; Slavé Petrovski; Erin Kahle; Jacques Fellay; Kevin Shianna; M Juliana McElrath; Katherine K Thomas; Jared M Baeten; Connie Celum; Anna Wald; Guy de Bruyn; James I Mullins; Edith Nakku-Joloba; Carey Farquhar; Max Essex; Deborah Donnell; James Kiarie; Bart Haynes; David Goldstein
Journal:  PLoS One       Date:  2011-12-12       Impact factor: 3.240

Review 6.  The Epidemiological Impact of STIs among General and Vulnerable Populations of the Amazon Region of Brazil: 30 years of Surveillance.

Authors:  Luiz Fernando Almeida Machado; Ricardo Roberto de Souza Fonseca; Maria Alice Freitas Queiroz; Aldemir Branco Oliveira-Filho; Izaura Maria Vieira Cayres-Vallinoto; Antonio Carlos Rosário Vallinoto; Marluísa de Oliveira Guimarães Ishak; Ricardo Ishak
Journal:  Viruses       Date:  2021-05-07       Impact factor: 5.048

7.  Family Aggregation of HTLV-1 Infection Associated with FAS -670A/G Polymorphism: A Case Report.

Authors:  Antonio C R Vallinoto; Bárbara B Santana; Maria A F Queiroz; Andrea N M R da Silva; Izaura M V Cayres-Vallinoto; Carlos A da Costa; Maisa S de Sousa; Ricardo Ishak
Journal:  Front Microbiol       Date:  2018-01-15       Impact factor: 5.640

8.  MBL2 gene polymorphisms in HHV-8 infection in people living with HIV/AIDS.

Authors:  Viviane Martha Santos de Morais; Elker Lene Santos de Lima; Georgea Gertrudes de Oliveira Mendes Cahú; Thaisa Regina Rocha Lopes; Juliana Prado Gonçales; Maria Tereza Cartaxo Muniz; Maria Rosângela Cunha Duarte Coêlho
Journal:  Retrovirology       Date:  2018-11-27       Impact factor: 4.602

Review 9.  Human lectins and their roles in viral infections.

Authors:  Christopher P Mason; Alexander W Tarr
Journal:  Molecules       Date:  2015-01-29       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.